1. Home
  2. MLTX vs WERN Comparison

MLTX vs WERN Comparison

Compare MLTX & WERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • WERN
  • Stock Information
  • Founded
  • MLTX 2021
  • WERN 1956
  • Country
  • MLTX Switzerland
  • WERN United States
  • Employees
  • MLTX N/A
  • WERN N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • WERN Trucking Freight/Courier Services
  • Sector
  • MLTX Health Care
  • WERN Industrials
  • Exchange
  • MLTX Nasdaq
  • WERN Nasdaq
  • Market Cap
  • MLTX 2.3B
  • WERN 2.0B
  • IPO Year
  • MLTX N/A
  • WERN N/A
  • Fundamental
  • Price
  • MLTX $38.33
  • WERN $28.30
  • Analyst Decision
  • MLTX Strong Buy
  • WERN Hold
  • Analyst Count
  • MLTX 8
  • WERN 15
  • Target Price
  • MLTX $80.50
  • WERN $35.13
  • AVG Volume (30 Days)
  • MLTX 489.2K
  • WERN 998.0K
  • Earning Date
  • MLTX 05-06-2025
  • WERN 04-29-2025
  • Dividend Yield
  • MLTX N/A
  • WERN 1.98%
  • EPS Growth
  • MLTX N/A
  • WERN N/A
  • EPS
  • MLTX N/A
  • WERN 0.55
  • Revenue
  • MLTX N/A
  • WERN $3,030,258,000.00
  • Revenue This Year
  • MLTX $103.42
  • WERN $3.79
  • Revenue Next Year
  • MLTX N/A
  • WERN $7.34
  • P/E Ratio
  • MLTX N/A
  • WERN $51.63
  • Revenue Growth
  • MLTX N/A
  • WERN N/A
  • 52 Week Low
  • MLTX $31.42
  • WERN $26.50
  • 52 Week High
  • MLTX $58.26
  • WERN $42.48
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 51.82
  • WERN 43.41
  • Support Level
  • MLTX $31.90
  • WERN $27.13
  • Resistance Level
  • MLTX $37.73
  • WERN $29.07
  • Average True Range (ATR)
  • MLTX 2.99
  • WERN 1.40
  • MACD
  • MLTX 0.29
  • WERN 0.11
  • Stochastic Oscillator
  • MLTX 74.53
  • WERN 49.72

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About WERN Werner Enterprises Inc.

Werner Enterprises Inc is a transportation and logistics company. The company has two reportable segments - TTS and Werner Logistics. It derives majority of its revenue from full-truckload transportation services and geographically from United States.

Share on Social Networks: